To develop an understanding of the structure–activity relationships for the inhibition of orthopoxviruses by nucleoside analogues, a variety of novel chemical entities were synthesized. These included a series of pyrimidine 5-hypermodified acyclic nucleoside analogues based upon recently discovered new leads, and some previously unknown “double-headed” or “abbreviated” nucleosides. None of the synthetic products possessed ...